CoChat

Ghrelin Infusion in Humans Induces Acute Insulin Resistance and Lipolysis Independent of Growth Hormone Signaling

Open access
Vestergaard, Esben Thyssen, Gormsen, Lars Christian, Jessen, Niels, Lund, Sten, Hansen, Troels Krarup, Moller, Niels, Jorgensen, Jens Otto Lunde · 2008 · Diabetes

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; none of the 34 sources its claims cite is checked for support yet.

Abstract

OBJECTIVE—Ghrelin is a gut-derived peptide and an endogenous ligand for the growth hormone (GH) secretagogue receptor. Exogenous ghrelin stimulates the release of GH (potently) and adrenocorticotropic hormone (ACTH) (moderately). Ghrelin is also orexigenic, but its impact on substrate metabolism is controversial. We aimed to study direct effects of ghrelin on substrate metabolism and insulin sensitivity in human subjects. RESEARCH DESIGN AND METHODS—Six healthy men underwent ghrelin (5 pmol · kg−1 · min−1) and saline infusions in a double-blind, cross-over study to study GH signaling proteins in muscle. To circumvent effects of endogenous GH and ACTH, we performed a similar study in eight hypopituitary adults but replaced with GH and hydrocortisone. The methods included a hyperinsulinemic-euglycemic clamp, muscle biopsies, microdialysis, and indirect calorimetry. RESULTS—In healthy subjects, ghrelin-induced GH secretion translated into acute GH receptor signaling in muscle. In the absence of GH and cortisol secretion, ghrelin acutely decreased peripheral, but not hepatic, insulin sensitivity together with stimulation of lipolysis. These effects occurred without detectable suppression of AMP-activated protein kinase phosphorylation (an alleged second messenger for ghrelin) in skeletal muscle. CONCLUSIONS—Ghrelin infusion acutely induces lipolysis and insulin resistance independently of GH and cortisol. We hypothesize that the metabolic effects of ghrelin provide a means to partition glucose to glucose-dependent tissues during conditions of energy shortage.

Overview

CoChat Summary

## TL;DR

This study found that ghrelin infusion in humans acutely increased lipolysis and reduced insulin-stimulated glucose disposal, even when GH and cortisol effects were controlled for in hypopituitary men. In healthy men, ghrelin also triggered endogenous GH release that led to STAT5 phosphorylation in skeletal muscle.

## Key findings

  • In 6 healthy men, ghrelin infusion (5 pmol·kg⁻¹·min⁻¹) caused GH to peak at 60 min: 33.3 ± 8.0 μg/l vs. 1.1 ± 0.9 μg/l with saline (P = 0.008), and increased serum FFAs: 1.0 ± 0.1 μg/l vs. 0.4 ± 0.04 μg/l (P = 0.003).
  • In those healthy subjects, skeletal muscle biopsies showed distinct STAT5 phosphorylation in all 6 subjects 30 min after the GH burst.
  • In 8 hypopituitary men, ghrelin caused an 80% increase in FFAs to 0.62 ± 0.03 mmol/l at 120 min (P < 0.05) and raised plasma glucose to 6.1 ± 0.2 mmol/l at 120 min (P = 0.009).
  • During the hyperinsulinemic-euglycemic clamp, ghrelin significantly decreased glucose infusion rate (GIR) (P < 0.01) and reduced the M value by ~60% (P < 0.001); it also reduced oxidative, nonoxidative, and total glucose disposal.

## Methods

  • Two human infusion studies were conducted under ethics/GCP approval and registered as NCT00116025 and NCT00139945.
  • Study 1: 6 healthy men (age 23 ± 1 years, BMI 23.5 ± 0.4 kg/m²) received saline or ghrelin infusion; a muscle biopsy was taken at 90 min.
  • Study 2: 8 hypopituitary men (age 53 ± 4 years, BMI 31.6 ± 1.0 kg/m²) on stable GH and hydrocortisone replacement underwent a randomized double-blind cross-over design with 5-h saline or ghrelin infusions, followed by a hyperinsulinemic-euglycemic clamp from 120 to 300 min; outcomes included tracer-derived glucose kinetics, indirect calorimetry, microdialysis, hormone/metabolite assays, and skeletal muscle signaling by Western blot and PI3K assay.

## Limitations

  • The paper states that in Study 2, muscle biopsies were obtained only in the basal period, which limits assessment of aberrations in insulin signaling pathways.
  • The authors note that infusion of ghrelin does not imitate the secretory pattern of endogenous ghrelin.
  • They also say the study was powered to detect effects on insulin sensitivity, so the lack of significant effects on lipid metabolism may be due to a β error.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2337/db08-0025

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIG. 1. Study protocol. Please refer to research design and methods for further details.
FIG. 1. Study protocol. Please refer to research design and methods for further details.CC BY-NC-ND · PubMed Central
FIG. 2. Hormones and metabolites during saline and ghrelin administration in study 2. A: Serum levels of ghrelin increased in response to ghrelin infusion to a plateau of 5.33 ± 0.45 μg/l in the basal state and a higher plateau of 5.86 ± 0.50 μg/l during the clamp period (mean ghrelin levels basal period vs. clamp period P = 0.001). B: Serum levels of GH. C: Serum levels of FFA. D: Serum levels of insulin. Serum insulin was similar during both basal and clamp conditions. E: Plasma glucose levels. F: Interstitial skeletal muscle glucose levels. Printed P values refer to two-way ANOVA significance levels. ▪, saline infusion; □, ghrelin infusion. All data are presented as means ± SE.
FIG. 2. Hormones and metabolites during saline and ghrelin administration in study 2. A: Serum levels of ghrelin increased in response to ghrelin infusion to a plateau of 5.33 ± 0.45 μg/l in the basal state and a higher plateau of 5.86 ± 0.50 μg/l during the clamp period (mean ghrelin levels basal period vs. clamp period P = 0.001). B: Serum levels of GH. C: Serum levels of FFA. D: Serum levels of insulin. Serum insulin was similar during both basal and clamp conditions. E: Plasma glucose levels. F: Interstitial skeletal muscle glucose levels. Printed P values refer to two-way ANOVA significance levels. ▪, saline infusion; □, ghrelin infusion. All data are presented as means ± SE.CC BY-NC-ND · PubMed Central
FIG. 3. A: Effects of ghrelin infusion on STAT5 phosphorylation and total STAT5 levels in skeletal muscle in healthy subjects (study 1). Values are means ± SE. B: Representative Western blots and quantitative bar-graphs regarding JAK/STAT, MAPK, AMPK, and insulin signaling pathways in skeletal muscle in hypopituitary patients (study 2) during ghrelin and saline infusion. PAS, pAkt substrate.
FIG. 3. A: Effects of ghrelin infusion on STAT5 phosphorylation and total STAT5 levels in skeletal muscle in healthy subjects (study 1). Values are means ± SE. B: Representative Western blots and quantitative bar-graphs regarding JAK/STAT, MAPK, AMPK, and insulin signaling pathways in skeletal muscle in hypopituitary patients (study 2) during ghrelin and saline infusion. PAS, pAkt substrate.CC BY-NC-ND · PubMed Central
FIG. 4. A: Glucose metabolism during saline and ghrelin administration in study 2. Hyperinsulinemic clamp. Glucose infusion rates and M value during saline and ghrelin administration. •, saline infusion; □, ghrelin infusion. B: Accumulative glucose infusion dosage during saline and ghrelin administration. The accumulative glucose dose was significantly decreased during the clamp period in the ghrelin study (P = 0.002). C: Glucose utilization during the terminal 30 min of basal and clamp periods in saline and ghrelin studies. Ghrelin did not significantly impact glucose metabolism in the basal period. During the clamp ghrelin infusion reduced the rates of oxidative, nonoxidative, and total glucose disposal (P = 0.009, P = 0.03, and P = 0.012, respectively). All data are presented as means ± SE.
FIG. 4. A: Glucose metabolism during saline and ghrelin administration in study 2. Hyperinsulinemic clamp. Glucose infusion rates and M value during saline and ghrelin administration. •, saline infusion; □, ghrelin infusion. B: Accumulative glucose infusion dosage during saline and ghrelin administration. The accumulative glucose dose was significantly decreased during the clamp period in the ghrelin study (P = 0.002). C: Glucose utilization during the terminal 30 min of basal and clamp periods in saline and ghrelin studies. Ghrelin did not significantly impact glucose metabolism in the basal period. During the clamp ghrelin infusion reduced the rates of oxidative, nonoxidative, and total glucose disposal (P = 0.009, P = 0.03, and P = 0.012, respectively). All data are presented as means ± SE.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 18 Not checked · 44 Own results and interpretations

22 more claims

Create a free account to see all 62 claims and to verify the 34 references still open.

See all claims — free account
  • Probably not a substantial claim. 29
  • The quote only partly states this claim. 6
  • It may state two separate claims as one. 10

Create a free account to see these claims.

Citations

Cites

Show all 28 references

Cited by

See all 157

Metadata

Authors
Vestergaard, E. T., Gormsen, L. C., Jessen, N., Lund, S., Hansen, T. K., Moller, N., & Jorgensen, J. O. L.
Affiliations
  • Aarhus University Hospital (DK)
  • From Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus, Denmark
Venue
Diabetes
Published
2008-12-01
Volume
57
Issue
12
Pages
3205-3210
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2105363738
Cited by
156
References
28
Citations by year
2026: 3 · 2025: 5 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 9 · 2019: 5 · 2018: 4 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 18 · 2013: 15 · 2012: 14
FWCI
6.54
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Aarhus Universitetshospital
  • World Anti-Doping Agency
  • Novo Nordisk
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
ghrelin, insulin resistance, lipolysis, growth hormone, growth hormone secretagogue receptor, skeletal muscle, AMPK, cortisol, substrate metabolism, energy crisis
MeSH terms
Adrenocorticotropic Hormone, Double-Blind Method, Humans, Hydrocortisone, Hypopituitarism, Infusions, Intravenous, Insulin Resistance, Lipolysis, Male, Middle Aged, Reference Values, Growth Hormone, Signal Transduction, Cross-Over Studies, Ghrelin, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ghrelin Infusion in Humans Induces Acute Insulin Resistance and Lipolysis Independent of Growth Hormone Signaling. https://app.cochat.ai/papers/10.2337/db08-0025
The paper
Vestergaard, E. T., Gormsen, L. C., Jessen, N., Lund, S., Hansen, T. K., Moller, N., & Jorgensen, J. O. L. (2008). Ghrelin Infusion in Humans Induces Acute Insulin Resistance and Lipolysis Independent of Growth Hormone Signaling. Diabetes. https://doi.org/10.2337/db08-0025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.